1
Clinical Trials associated with EphA2-targeted CAR-DC(Second Affiliated Hospital, School of Medicine, Zhejiang University)Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer
This is an open-label, single-arm clinical study designed to evaluate the safety and preliminary efficacy of EphA2-targeted CAR-DC combined with CAR-T cell therapy in patients with non-small cell lung cancer.
100 Clinical Results associated with EphA2-targeted CAR-DC(Second Affiliated Hospital, School of Medicine, Zhejiang University)
100 Translational Medicine associated with EphA2-targeted CAR-DC(Second Affiliated Hospital, School of Medicine, Zhejiang University)
100 Patents (Medical) associated with EphA2-targeted CAR-DC(Second Affiliated Hospital, School of Medicine, Zhejiang University)
100 Deals associated with EphA2-targeted CAR-DC(Second Affiliated Hospital, School of Medicine, Zhejiang University)